Ewelina Morawa, MD Executive Medical Director CRISPR Therapeutics discusses Allogeneic Anti-CD70 CAR T Cells ?for Renal Cell Carcinoma From the Seventeenth International Kidney Cancer International Symposium 2018 in Miami FL.
Advertisement
Advertisement
[the_ad id="32629"]